Navigation Links
Pharmacopeia Announces Management Team Changes
Date:2/28/2008

PRINCETON, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced advancements for two members of its management team. Rene Belder, M.D., Vice President, Clinical and Regulatory Affairs, has been promoted to Senior Vice President, Clinical and Regulatory Affairs, and the role of S. David Kimball, Ph.D., Senior Vice President, Chemistry and Preclinical Chemical Development, has been expanded to include all of research, and his title has been changed to Senior Vice President, Discovery. The company also announced that David M. Floyd, Ph.D. is retiring effective March 31, 2008 from his position as Executive Vice President and Chief Scientific Officer. However, Dr. Floyd will rejoin Pharmacopeia's scientific advisory board and continue to consult for the company in the area of scientific direction and strategy.

"David Floyd has had an important impact on Pharmacopeia since arriving at the company more than three years ago. He has facilitated the successful transformation of Pharmacopeia into a clinical stage development company by helping to build our broad pipeline," said Les Browne, Ph.D., Pharmacopeia's President and Chief Executive Officer. "While we are saddened to see him leave his day-to-day position, we are very pleased that he will once again be a member of our scientific advisory board and continue to provide his invaluable insight as a key consultant."

"I view my tenure as a member of the Pharmacopeia executive management team as very rewarding and look forward to remaining connected with the company through my SAB and consulting roles," stated Dr. Floyd. "We have made tremendous progress over the last thr
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference
2. Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. West Pharmaceutical Services Announces Quarterly Dividend
6. Beijing 2008 Olympic Games Vegetable Supplier Considering Kiwa as a Supplier of Bio-Fertilizers & Kiwa Announces CEO Interview with WallSt.net
7. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
8. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
9. DARA BioSciences, Inc. Announces Appointment of New Director to Board
10. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
11. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... NEW YORK and MUMBAI, India ... (TCS), (BSE: 532540, NSE: TCS) a leading global IT ... has been designated as a Leader in Worldwide Life ... IDC, in the " IDC MarketScape: Worldwide Life Science ... 2015) report. The report evaluated eight ...
(Date:6/26/2015)... , June 23, 2015 ... the addition of the "Global Cancer Biosimilars ... Market introduction of cancer biosimilar is ... commercialization potential. Chemotherapeutic drugs have dominated the cancer ... have been introduced in past few years. They ...
(Date:6/26/2015)... -- The report "Biolubricants Market by Type ... Chainsaw oils, Mold Release Agents), End Use (Industrial, Commercial ... and Forecasts to 2020" published by MarketsandMarkets, The Biolubricants ... at a CAGR of 6.27% between 2015 and 2020. ...   66 Figures spread through 170 Pages and in-depth ...
(Date:6/25/2015)... Last June, a dedicated global team of Ebola researchers began ... sequencing. Their research, which was written on the research platform ... (Park 2015) , reveals critical information about how ... recent Ebola outbreak. Today Authorea is pleased to ... edit history of the paper are available to the ...
Breaking Biology Technology:TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4Global Cancer Biosimilars Market Opportunity Outlook 2Global Cancer Biosimilars Market Opportunity Outlook 3Biolubricants Market Worth $2,972.13 Million by 2020 2Biolubricants Market Worth $2,972.13 Million by 2020 3Open Science Takes Major Leap Forward 2
... Cerecor Inc. , a biopharmaceutical company focused on the ... activity is in the human nervous system, announced today ... overallotment of its January 2012 Series A preferred stock ... including members of Cerecor,s Board of Directors , ...
... American researchers have shown that prospective magnetic fusion power ... used for the production of weapon-usable materials than nuclear ... The researchers, from Princeton University, found that if nuclear ... there is little risk of fissile materials being produced ...
... N.Y. Jie Lian, assistant professor in the Department ... Institute, has won a prestigious Faculty Early Career Development ... Lian will use the five-year, $500,000 award to further ... in nuclear energy systems. The CAREER Award is given ...
Cached Biology Technology:Cerecor Raises $22 Million Series A Financing 2Fusion presents low proliferation risk, experts conclude 2Rensselaer professor Jie Lian receives NSF CAREER Award 2
(Date:6/25/2015)...  TAKE Solutions Ltd., a global business technology solutions ... Patent and Trademark Office (USPTO) for its "Method for ... Clinical Accelerators to reduce the time taken to standardize ... without the accelerators), thus reducing time to market. ... the heart of the patented Clinical Data Standardization Process ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... December 7, 2012 More than 100 academic ... major world-wide initiative: Mathematics of Planet Earth (MPE) ... made by mathematics in tackling global problems, including ... climate change; sustainability; and pandemics. MPE2013 partners will ...
... plant growth patterns are influenced by a variety of ... roots exhibit characteristic behaviours called ,waving, and ,skewing, which ... plants grown on the International Space Station (ISS) ... published in BioMed Central,s open access journal BMC ...
... a biological adaptation that enables them to thrive in the ... on the trait appears to be linked to different genes ... University scientist and colleagues shows. The adaptation is the ... of hemoglobin, the oxygen-carrying protein in red blood cells. Members ...
Cached Biology News:Mathematicians tackle global issues 2Mathematicians tackle global issues 3What happens to plant growth when you remove gravity? 2Different genes behind same adaptation to thin air 2
... The Neural Stem Cell Expansion Kit - Neurosphere ... neural stem cell expansion as neurospheres in ... specially formulated N-2 Plus Media Supplement, which has ... K.K. et al . (1996) Genes & ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... E. coli strain containing an overproducing clone ... Reverse Transcriptase catalyzes the polymerization of DNA ... Full-length copies of large mRNAs, >10 kb, ... a much lower RNase H activity than ...
... RQ1 RNase-Free DNase is a preparation ... or double-stranded DNA to produce 3-hydroxyl ... use in applications where maintaining the ... DNase is qualified for use with ...
Biology Products: